Macquarie lowered the firm’s price target on Braze (BRZE) to $35 from $40 and keeps a Neutral rating on the shares. Braze’s top line beat by 2%, but profitability was lower as a result of its recent OfferFit acquisition, while its dollar-based net retention fell to 109%, with continued excess churn impacting reaccelerated revenue growth, the analyst tells investors in a research note. The firm remains on the sidelines with the stock well priced.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRZE:
- Braze price target lowered to $43 from $47 at TD Cowen
- Braze price target lowered to $45 from $47 at JPMorgan
- Braze price target lowered to $45 from $75 at Loop Capital
- Braze price target lowered at Raymond James, says pullback a buying opportunity
- Braze price target lowered to $40 from $45 at Stifel